| NCT ID | NCT06120231 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dartmouth-Hitchcock Medical Center |
| Condition | Spinal Fusion |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-12-01 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2023-12-01 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overarching aim of this project is to modulate the pulse-width during stimulation of pedicle screws and record the response thresholds associated with each PWM setting. During this initial phase of the investigation, no further data will be collected.
Eligibility Criteria
Inclusion Criteria: * A patient will be eligible for study participation once they have been booked for a surgery involving pedicle screw placement and intraoperative neuromonitoring. Exclusion Criteria: * The study excludes neonates, minors, pregnant women, prisoners and cognitively impaired patients.
Contact & Investigator
Linton Evans, Dr.
PRINCIPAL INVESTIGATOR
Dartmouth-Hitchcock Medical Center
Frequently Asked Questions
Who can join the NCT06120231 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Fusion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06120231 currently recruiting?
Yes, NCT06120231 is actively recruiting participants. Contact the research team at Beverly..A.Allen@hitchcock.org for enrollment information.
Where is the NCT06120231 trial being conducted?
This trial is being conducted at Lebanon, United States.
Who is sponsoring the NCT06120231 clinical trial?
NCT06120231 is sponsored by Dartmouth-Hitchcock Medical Center. The principal investigator is Linton Evans, Dr. at Dartmouth-Hitchcock Medical Center. The trial plans to enroll 50 participants.